Jefferies Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Jefferies Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,400	Closed	-$5.05M	–	2064
2023 Q4	$5.05M	Buy	12,400 +3,400	+38%	+$1.26M	0.03%	401
2023 Q3	$3.13M	Sell	9,000 -1,100	-11%	-$385K	0.03%	475
2023 Q2	$3.55M	Buy	+10,100	New	+$3.4M	0.03%	467
2023 Q1	–	Sell	-5,200	Closed	-$1.5M	–	2027
2022 Q4	$1.5M	Buy	+5,200	New	+$1.58M	0.01%	755

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jefferies Financial Group's VRTX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 24% in Q1 2026, selling an estimated $3.53M and leaving 23,810 shares worth $10.6M. The position accounts for 0.07% of the portfolio, ranked #199.

Jefferies Financial Group first reported a position in VRTX in Q1 2016 and has held it in 15 quarters since. The position peaked at $28.3M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Jefferies Financial Group held 23,810 shares of Vertex Pharmaceuticals worth $10.6M as of Q1 2026.
Jefferies Financial Group sold 7,562 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.53M.
Vertex Pharmaceuticals made up 0.07% of Jefferies Financial Group's portfolio in Q1 2026, its #199 holding.
Jefferies Financial Group first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 15 quarters since.
Jefferies Financial Group's Vertex Pharmaceuticals position peaked at $28.3M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.